Maison de santé - Au Fil de l'Eau.

The medical center is at the forefront of cardiovascular research specifically targeting patients with type 2 diabetes who have not experienced prior cardiovascular events. The focus is on improving cardiovascular outcomes through innovative therapeutic strategies.

• Colchicine and Aspirin Efficacy
• Cardiovascular Risk Reduction
• Prevention of Cardiovascular Events

By exploring the combined and individual effects of colchicine and non-enteric coated aspirin, the center aims to enhance the standard of care for high-risk diabetic patients, potentially reducing the incidence of severe cardiovascular events.